JNJ Trading Analysis - 10/23/2026 03:08 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for Johnson & Johnson (JNJ) that may relate to the current data environment:

• JNJ declared a quarterly dividend of $1.34 per share with an ex-dividend date of 2026-11-24, supporting its long-term income narrative.
• The company continues to face ongoing litigation over talc-related liabilities, a recurring overhang for the pharmaceutical giant.
• JNJ's medtech segment has shown steady procedure-volume recovery, partially offsetting slower pharmaceutical growth in 2026.
• No major earnings catalyst appears imminent before the next major options expiration of 2026-11-20, though macro rate trends may influence defensives.
• Context: The bullish options flow and recent daily pop to $268.63 align with a defensive rotation, but technicals show no clear trend direction per embedded indicators.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for JNJ:

• Trailing P/E is 38.90 with trailing EPS of $6.68; valuation appears elevated versus typical consumer-defensive peers, though no PEG ratio is available (null).
• Dividend yield is 2.07% with a dividend rate of $5.36 and ex-dividend date of 2026-11-24, reflecting income stability.
• Market cap is $634,454,109,730.00 with shares outstanding of 2,409,899,000.00 and institutional ownership at 50.10%.
• Beta is very low at 0.07, indicating minimal systemic volatility relative to the broader market.
• 52-week range is $184.66 to $281.07; current price near $268.63 sits in the upper-middle of the annual range.
• Key missing data: revenue growth, profit margins, ROE, debt/equity, and free cash flow are all null, limiting deep fundamental quality assessment.
• Analyst consensus and target mean price are null; no street projection is available in the data.
• Fundamentals (stable dividend, low beta) diverge from the technical picture, which shows no clear direction despite bullish options sentiment.

Current Market Position

From the embedded daily and minute-bar data:

Current price per indicators is $268.63 (as of 2026-10-22 close). On 2026-10-22, JNJ opened at $260.54, hit high $269.67, low $259.04, and closed $268.63 on volume of 5,421,638. On 2026-10-23 minute bars, price pulled back from $268.63 (15:50 2026-10-22) to $263.27 by 14:40 2026-10-23, with a volume spike of 2,598,415 at 14:30.

Key levels from data: 30-day range high $275.23, low $245.17; Bollinger upper $272.13, lower $246.71; daily low on 2026-10-13 was $245.17 (volume 11,783,106). Intraday momentum on 2026-10-23 shows fading strength after the 2026-10-22 rally.

Technical Analysis

SMA alignment: 5-day ($258.85) and 20-day ($259.42) are below 50-day ($265.20), but price ($268.63) is above all three, showing short-term catch-up. No golden/death cross on these marks. RSI 61.60 indicates moderate bullish momentum, not overbought. MACD is negative (-1.63) below signal (-1.31) with negative histogram (-0.33), showing bearish pressure under price strength. Bollinger middle is $259.42; price is above middle and near upper $272.13 (expansion, not squeeze). 30-day high $275.23, low $245.17; price at $268.63 is ~78% up the range.

True Sentiment Analysis (Delta 40-60 Options)

From the True Sentiment options data (methodology: Delta 40-60 only):

Call Dollar Volume: $694,410.00 (66.00%) Put Dollar Volume: $358,380.00 (34.00%) Total: $1,052,790.00

Sentiment is Bullish with 655 call contracts vs 345 put contracts. Pure directional conviction skews bullish near-term. Divergence: options are bullish while MACD and spread recommender note "technicals show no clear direction" — a mismatch between flow and trend.

Key Price Levels (Observational Only)